A
new variant of the coronavirus is spreading across the globe. It was first identified in the United Kingdom, where it is rapidly spreading, and has been found in multiple countries. Viruses mutate all the time, often with no impact, but this one appears to be more transmissible than other variants—meaning it spreads more easily. Barely one day after officials announced that America’s first case of the variant had been found in the United States, in a Colorado man with no history of travel, an additional case was found in California. https://www.infinitiafrica.com/hub/videos-hakone-ekiden-97th-xtv01.html
https://www.infinitiafrica.com/hub/videos-hakone-ekiden-97th-xtv02.html
https://www.infinitiafrica.com/hub/videos-hakone-ekiden-97th-xtv03.html
https://www.infinitiafrica.com/hub/videos-hakone-ekiden-97th-xtv04.html
https://www.infinitiafrica.com/hub/videos-hakone-ekiden-97th-xtv05.html
https://driftahalle.lv/videos-hakone-ekiden-97th-xtv06.html
https://driftahalle.lv/videos-hakone-ekiden-97th-xtv07.html
https://driftahalle.lv/videos-hakone-ekiden-97th-xtv08.html
https://driftahalle.lv/videos-hakone-ekiden-97th-xtv09.html There are still many unknowns, but much concern has focused on whether this new variant would throw off vaccine efficacy or cause more severe disease—with some degree of relief after an initial study indicated that it did not do either. And while we need more data to feel truly reassured, many scientists believe that this variant will not decrease vaccine efficacy much, if at all. Health officials have started emphasizing the lack of evidence for more severe disease. All good and no cause for alarm, right? Wrong. A more transmissible variant of COVID-19 is a potential catastrophe in and of itself. If anything, given the stage in the pandemic we are at, a more transmissible variant is in some ways much more dangerous than a more severe variant. That’s because higher transmissibility subjects us to a more contagious virus spreading with exponential growth, whereas the risk from increased severity would have increased in a linear manner, affecting only those infected. RECOMMENDED READING A road meanders through a field of syringes, which look like trees, toward a giant virus, which looks like a setting sun. Where Year Two of the Pandemic Will Take Us ED YONG Two children look out a window It’s Time to Hunker Down ZEYNEP TUFEKCI High-school students socially distance in Greece. This Overlooked Variable Is the Key to the Pandemic ZEYNEP TUFEKCI Increased transmissibility can wreak havoc in a very, very short time—especially when we already have uncontrolled spread in much of the United States. The short-term implications of all this are significant, and worthy of attention, even as we await more clarity from data. In fact, we should act quickly especially as we await more clarity—lack of data and the threat of even faster exponential growth argue for more urgency of action. If and when more reassuring data come in, relaxing restrictions will be easier than undoing the damage done by not having reacted in time.
From the January/February 2021 issue: How science beat the virus To understand the difference between exponential and linear risks, consider an example put forth by Adam Kucharski, a professor at the London School of Hygiene & Tropical Medicine who focuses on mathematical analyses of infectious-disease outbreaks. Kucharski compares a 50 percent increase in virus lethality to a 50 percent increase in virus transmissibility. Take a virus reproduction rate of about 1.1 and an infection fatality risk of 0.8 percent and imagine 10,000 active infections—a plausible scenario for many European cities, as Kucharski notes. As things stand, with those numbers, we’d expect 129 deaths in a month. If the fatality rate increased by 50 percent, that would lead to 193 deaths. In contrast, a 50 percent increase in transmissibility would lead to a whopping 978 deaths in just one month—assuming, in both scenarios, a six-day infection-generation time.